Using Blinatumomab in Acute Lymphoblastic Leukemia
0 Pogledi
• 06/15/23
0
0
Ugraditi
administrator
Pretplatnici
The discussants, Bijal D. Shah, MD, and Raoul Tibes, MD, PhD, elaborate on the administration and safety of bi-specific T-cell engager, blinatumomab, in the treatment of acute lymphoblastic leukemia.
Prikaži više
Komentari na Facebooku
SORT BY-
Najbolji komentari
-
Najnoviji komentari